Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma

NCT05705791 · clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
33
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris